You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

temozolomide

Showing 51 - 75 of 556
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PCNSL Trial in Shanghai (Zanubrutinib, Rituximab, Methotrexate)

Not yet recruiting
  • PCNSL
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jun 8, 2023

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

Neuroblastoma Trial in Worldwide (Bevacizumab, Temozolomide, Irinotecan)

Active, not recruiting
  • Neuroblastoma
  • Vienna, Austria
  • +9 more
Feb 14, 2022

Metastatic Pancreatic Neuroendocrine Tumor, Unresectable Pancreatic Neuroendocrine Carcinoma Trial (Lutetium Lu 177 Dotatate,

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • Unresectable Pancreatic Neuroendocrine Carcinoma
  • Lutetium Lu 177 Dotatate
  • +4 more
  • (no location specified)
Feb 10, 2022

Glioblastoma Trial (Gabapentin, Sulfasalazine, Memantine)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Dec 15, 2022

Extensive Stage Lung Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma Trial in

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +5 more
  • Atezolizumab
  • Temozolomide
  • Indianapolis, Indiana
  • +2 more
Oct 26, 2022

Malignant Tumor, Malignant Tumor of Brain Trial in Taiwan (NBM-BMX Capsule, Temozolomide, Standard radiotherapy)

Recruiting
  • Malignant Neoplasm
  • Malignant Neoplasm of Brain
  • NBM-BMX Capsule
  • +2 more
  • Hualien City, Taiwan
  • +4 more
Aug 22, 2023

Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guandong, Guangzhou (Methotrexate, Ibrutinib, Temozolomide)

Recruiting
  • Primary Central Nervous System Lymphoma
  • +2 more
  • Guandong, Guangdong, China
  • +2 more
Apr 6, 2022

Metastatic Colorectal Cancer Trial in Milan (Bevacizumab, Irinotecan, Leucovorin)

Recruiting
  • Metastatic Colorectal Cancer
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

Glioblastoma Trial in Ann Arbor (Dose-Intensified Radiotherapy, Temozolomide, Adjuvant temozolomide)

Recruiting
  • Glioblastoma
  • Dose-Intensified Radiotherapy
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 16, 2021

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Not yet recruiting
  • Locally Advanced Leiomyosarcoma
  • +8 more
  • (no location specified)
Jul 6, 2022

Colorectal Cancer Trial (Irinotecan, Temozolomide)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 1, 2022

Small Cell Lung Cancer Trial in Boston (Olaparib, Temozolomide)

Active, not recruiting
  • Small Cell Lung Cancer
  • Boston, Massachusetts
  • +2 more
Jan 24, 2022

Glioblastoma Multiforme Trial in Washington, Baltimore (Temozolomide)

Completed
  • Glioblastoma Multiforme
  • Temozolomide
  • Washington, District of Columbia
  • +2 more
Nov 17, 2021

Glioblastoma Multiforme Trial in Cleveland (biological, drug, other, procedure, radiation)

Active, not recruiting
  • Glioblastoma Multiforme
  • MGMTP140K-encoding retroviral vector
  • +6 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
May 6, 2022

Adenocarcinoma - GEJ, Cancer of Esophagus Trial in Cambridge (Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month)

Recruiting
  • Adenocarcinoma - GEJ
  • Cancer of Esophagus
  • Temozolomide
  • +3 more
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Oct 6, 2021

Neuroblastoma Trial in United States (TPI 287, Temozolomide, Irinotecan)

Terminated
Has Results
  • Neuroblastoma
  • TPI 287
  • +2 more
  • Phoenix, Arizona
  • +7 more
Apr 20, 2022

Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

Not yet recruiting
  • Glioblastoma Multiforme
  • +3 more
  • P140K-MGMT
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jul 4, 2022

Glioblastoma Trial in Louisville (Hypofractionated radiotherapy, Temozolomide)

Recruiting
  • Glioblastoma
  • Hypofractionated radiotherapy
  • Temozolomide
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Oct 22, 2021

Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

Completed
  • Metastatic Colorectal Cancer
  • Temozolomide
  • +2 more
  • Milan, MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

Melanoma Trial in Shanghai (SHR-1701, Temozolomide)

Not yet recruiting
  • Melanoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 1, 2021

Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Los Angeles, San Diego (biological, drug, other, genetic)

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • bevacizumab
  • +5 more
  • Los Angeles, California
  • +2 more
Feb 10, 2022

Glioblastoma Trial in Boston (Temozolomide, Bavituximab, Radiation)

Active, not recruiting
  • Glioblastoma
  • Temozolomide
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 27, 2021

Ewing's Sarcoma Trial in United States (Vigil, Temozolomide, Irinotecan)

Completed
Has Results
  • Ewing's Sarcoma
  • Vigil
  • +4 more
  • Little Rock, Arkansas
  • +5 more
Dec 20, 2022